Loading…
Galaxy Medicare (GML)₹16.85−4.80%Medical Equipment & Supplies
In the Mar 2026 quarter (standalone), Galaxy Medicare reported sales of ₹21.21 Cr, down 3.3% from Mar 2025, and net profit of ₹1.39 Cr, down 15.8% year on year. For the year to Mar 2026, sales were ₹39.89 Cr and net profit ₹3.41 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 17.19 | 21.93 | 18.69 | 21.21 |
| Expenses | 14.71 | 19.77 | 15.85 | 19.85 |
| Operating Profit | 2.51 | 2.16 | 2.87 | 1.38 |
| OPM % | 14.6% | 9.9% | 15.4% | 6.5% |
| Other Income | 0.56 | 0.53 | 0.34 | 0.99 |
| Interest | 0.37 | 0.30 | 0.10 | 0.15 |
| Depreciation | 0.26 | 0.26 | 0.31 | 0.26 |
| Profit before tax | 2.43 | 2.12 | 2.79 | 1.95 |
| Tax % | 29.3% | 21.7% | 27.3% | 27.2% |
| Net Profit | 1.70 | 1.65 | 2.01 | 1.39 |
| EPS (Rs) | 1.45 | 1.41 | 1.34 | 0.93 |
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 28.50 | 30.89 | 35.77 | 38.80 | 39.89 |
| Expenses | 26.37 | 28.54 | 30.80 | 34.08 | 35.68 |
| Operating Profit | 2.17 | 2.36 | 4.98 | 4.72 | 4.24 |
| OPM % | 7.6% | 7.7% | 14.0% | 12.2% | 10.7% |
| Other Income | 0.51 | 1.73 | 1.19 | 1.08 | 1.32 |
| Interest | 0.79 | 0.94 | 0.93 | 0.73 | 0.27 |
| Depreciation | 0.83 | 1.13 | 0.49 | 0.51 | 0.56 |
| Profit before tax | 1.05 | 2.01 | 4.75 | 4.55 | 4.73 |
| Tax % | 30.7% | 21.4% | 21.5% | 25.5% | 27.3% |
| Exceptional items | −0.03 | 0.70 | 0.33 | 0.07 | 0.00 |
| Net Profit | 0.71 | 1.56 | 3.70 | 3.36 | 3.41 |
| EPS (Rs) | 2.58 | 5.18 | 3.14 | 2.85 | 2.26 |
| Dividend payout % | 9.8% | 0.0% | 0.0% | 0.0% | 33.3% |
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 2.81 | 3.05 | 11.89 | 11.89 | 15.20 |
| Reserves | 12.86 | 14.75 | 9.48 | 12.26 | 25.09 |
| Borrowings | 8.77 | 9.14 | 8.11 | 4.60 | 4.19 |
| Other Liabilities | 5.44 | 5.36 | 3.03 | 2.71 | 4.20 |
| Total Liabilities | 29.88 | 32.30 | 32.51 | 31.46 | 48.68 |
| Fixed Assets | 13.97 | 14.60 | 14.42 | 14.15 | 15.04 |
| CWIP | 0.21 | 0.07 | 0.00 | 0.00 | 0.00 |
| Investments | 2.99 | 2.70 | 3.12 | 2.83 | 2.88 |
| Other Assets | 12.71 | 14.93 | 14.97 | 14.48 | 30.76 |
| Inventories | 3.31 | 4.87 | 6.19 | 4.93 | 5.63 |
| Trade receivables | 7.31 | 9.06 | 7.34 | 6.90 | 7.63 |
| Cash & equivalents | 0.33 | 0.35 | 0.36 | 0.47 | 13.20 |
| Total Assets | 29.88 | 32.30 | 32.51 | 31.46 | 48.68 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | 5.57 | — | 3.64 | 2.70 | 4.48 | 1.76 |
| Cash from investing activity | −4.45 | — | −1.90 | −0.64 | 0.31 | −13.87 |
| Cash from financing activity | −1.12 | — | −1.81 | −2.09 | −4.74 | 12.14 |
| Net cash flow | 0.00 | — | −0.06 | −0.02 | 0.08 | −0.04 |
| Capex | 4.54 | 1.92 | 0.88 | 0.68 | 0.24 | 1.61 |
| Free cash flow | 1.10 | — | 2.91 | 2.51 | 4.38 | 0.22 |
| CFO / OP % | 272.9% | — | 169.9% | 75.9% | 118.0% | 67.9% |
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 92 | 106 | 74 | 64 | 69 |
| Inventory days | 74 | 101 | 124 | 85 | 82 |
| Days payable | 102 | 92 | 32 | 22 | 36 |
| Cash conversion cycle | 66 | 116 | 166 | 127 | 115 |
| Working capital days | 1 | 36 | 57 | 69 | 95 |
| ROCE % | — | — | 18.6% | 17.7% | 13.6% |
For the Mar 2026 quarter, Galaxy Medicare reported sales of ₹21.21 Cr, down 3.3% year on year and net profit of ₹1.39 Cr, down 15.8% year on year. The operating margin was 6.5%.
Galaxy Medicare's sales for the year to Mar 2026 were ₹39.89 Cr.
Net profit for the year to Mar 2026 was ₹3.41 Cr. Earnings per share over the same trailing period were ₹2.26.
Galaxy Medicare reported borrowings of ₹4.19 Cr at Mar 2026, against cash and equivalents of ₹13.20 Cr.
Cash from operations was ₹1.76 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.22 Cr.